Preoperative Embolization of Cerebral Arteriovenous Malformations with Onyx

References

1. ↵
   Haw CS, terBrugge K, Willinsky R, et al. Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 2006;104:226–32

   CrossRefPubMed
2. Purdy PD, Batjer HH, Risser RC, et al. Arteriovenous malformations of the brain: choosing embolic materials to enhance safety and ease of excision. J Neurosurg 1992;77:217–22

   PubMed
3. Purdy PD, Batjer HH, Samson D, et al. Intraarterial sodium amytal administration to guide preoperative embolization of cerebral arteriovenous malformations. J Neurosurg Anesthesiol 1991;3:103–06

   PubMed
4. ↵
   Samson D, Ditmore QM, Beyer CW Jr. Intravascular use of isobutyl 2-cyanoacrylate: Part 1. Treatment of intracranial arteriovenous malformations. Neurosurgery 1981;8:43–51

   PubMedWeb of Science
5. ↵
   Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83

   PubMedWeb of Science
6. ↵
   Taylor CL, Dutton K, Rappard G, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 2004;100:810

   PubMedWeb of Science
7. ↵
   Weber W, Kis B, Siekmann R, et al. Endovascular treatment of intracranial arteriovenous malformations with Onyx: technical aspects. AJNR Am J Neuroradiol 2007;28:371–77

   Abstract/FREE Full Text
8. ↵
   Debrun GM, Aletich V, Ausman JI, et al. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112–20; discussion 120–21

   CrossRefPubMed
9. Frizzel RT, Fisher WS 3rd. Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 1995;37:1031–39; discussion 1039–40

   PubMedWeb of Science
10. Hartmann A, Pile-Spellman J, Stapf C, et al. Risk of endovascular treatment of brain arteriovenous malformations. Stroke 2002;33:1816–20

    Abstract/FREE Full Text
11. n-BCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002;23:748–55

    Abstract/FREE Full Text
12. ↵
    Valavanis A, Yaçsargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 1998;24:131–214

    PubMed
13. ↵
    Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984–95; discussion 995–97

    CrossRefPubMedWeb of Science
14. ↵
    Mounayer C, Hammami N, Piotin M, et al. Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 2007;28:518–23

    Abstract/FREE Full Text
15. ↵
    Hamada J, Kai Y, Morioka M, et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg 2002;97:881–88

    PubMed
16. ↵
    van Rooij WJ, Sluzewski M, Beute GN. Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 2007;28:172–77; discussion 178

    Abstract/FREE Full Text
17. ↵
    Weber W, Kis B, Siekmann R, et al. Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 2007;61:244–52; discussion 252–54

    CrossRefPubMedWeb of Science
18. ↵
    Pasqualin A, Barone G, Cioffi F, et al. The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations. Neurosurgery 1991;28:370–79

    CrossRefPubMedWeb of Science
19. ↵
    Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 2008;50:589–97

    CrossRefPubMedWeb of Science